Cargando…
CD140a identifies a population of highly myelinogenic, migration-competent, and efficiently engrafting human oligodendrocyte progenitor cells
Experimental models of myelin disorders can be treated by the transplantation of oligodendrocyte progenitor cells (OPCs) into the affected brain or spinal cord. OPCs express gangliosides recognized by MAb A2B5, but this marker also identifies lineage-restricted astrocytes and immature neurons. To es...
Autores principales: | Sim, Fraser J., McClain, Crystal, Schanz, Steven, Protack, Tricia L., Windrem, Martha S., Goldman, Steven A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3365580/ https://www.ncbi.nlm.nih.gov/pubmed/21947029 http://dx.doi.org/10.1038/nbt.1972 |
Ejemplares similares
-
Transcription factor–mediated reprogramming of fibroblasts to expandable, myelinogenic oligodendrocyte progenitor cells
por: Najm, Fadi J., et al.
Publicado: (2013) -
Robust Generation of Oligodendrocyte Progenitors from Human Neural Stem Cells and Engraftment in Experimental Demyelination Models in Mice
por: Neri, Margherita, et al.
Publicado: (2010) -
Motor Learning Promotes Remyelination via New and Surviving Oligodendrocytes
por: Bacmeister, Clara M., et al.
Publicado: (2020) -
Network-Based Genomic Analysis of Human Oligodendrocyte Progenitor Differentiation
por: Pol, Suyog U., et al.
Publicado: (2017) -
Neural stem cells and oligodendrocyte progenitor cells compete for remyelination in the corpus callosum
por: Moyon, Sarah, et al.
Publicado: (2023)